Twin Tree Management
LEGN icon

Twin Tree Management’s Legend Biotech LEGN Stock Holding History

Twin Tree Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$48.2K – 1398
2023
Q1 		$48.2K Buy
+1,000
New +$48.9K ﹤0.01% 1171

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Twin Tree Management's LEGN Position: Q2 2023 in Review

Twin Tree Management sold out of Legend Biotech (LEGN) in Q2 2023, closing a stake of 344 shares — an estimated $16.6K sold.

Twin Tree Management first reported a position in LEGN in Q1 2023 and held it in 1 quarter. The position peaked at $16.6K in Q1 2023. 194 funds tracked by Wall St. Rank hold LEGN as of Q2 2023.

  • Twin Tree Management reported no remaining Legend Biotech position as of Q2 2023 after selling out during the quarter.
  • Twin Tree Management sold 344 Legend Biotech shares in Q2 2023, an estimated $16.6K.
  • Twin Tree Management first reported a position in Legend Biotech in Q1 2023 and held it in 1 quarter.
  • Twin Tree Management's Legend Biotech position peaked at $16.6K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2023.

Based on Twin Tree Management's 13F filing for Q2 2023, filed 11 Aug 2023.